QT Interval Prolongation in the Pediatric Oncologic Population on Methadone
- PMID: 30830033
- PMCID: PMC9121626
- DOI: 10.1097/MPH.0000000000001444
QT Interval Prolongation in the Pediatric Oncologic Population on Methadone
Abstract
Studies have been conducted on adults prescribed with methadone to determine the necessary frequency of QTc monitoring but no consensus has been reached and no similar research has been conducted in the pediatric population. The objective of this retrospective study was to determine the occurrence rate of QTc interval prolongation associated with methadone use in a pediatric oncologic population. In total, 18% of patients developed QTc interval prolongation. These patients had longer baseline QTc intervals and were on more QTc interval-prolonging medications. Our data suggest that these variables may be able to risk stratify patients who require more frequent monitoring.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Cruciani R. Methadone: to EKG or Not to EKG… that is still the question. J Pain Symptom Manag. 2008;5:545–552. - PubMed
-
- Walker G, Wilcock A, Carey AM, et al. Prolongation of theQT interval in palliative care patients. J Pain Symptom Manag. 2003;269:855–859. - PubMed
-
- Mercandante S, Prestia G, Adile C, et al. Changes of QTcinterval after opioid switching to oral methadone. Support Care Cancer. 2013;21:3421–3424. - PubMed
-
- Stimmel B, Lipski J, Swartz M, et al. Electrocardiographicchanges in heroins, methadone and multiple drug abuse: a postulated mechanism of sudden death in narcotic addicts.. Proc Natl Conf Methadone Treat. 1973;1:706–710. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical